The forecast for HIV-AIDS mortality among females in the U.S. from 2024 to 2028 remains consistent, with an estimated ratio of 800 deaths per hundred thousand women each year. There is no year-on-year percentage change observed over this forecast period, reflecting a stable trend in mortality rates. As of 2023, the figure stood at the same level in real data, indicating no significant variation from historical trends. This stability implies a stagnant CAGR of 0% as well.
Future trends to watch for include advancements in medical research and healthcare access, which could potentially reduce mortality rates. Continuous monitoring of socio-economic factors and health policies will be crucial to understand their influence on these persistent rates. Additionally, innovations in treatment and prevention could alter the existing forecast.
